FDA.reportPublic FDA data

denileukin diftitox-cxdl 0.3 MG Injection [Lymphir]

RxCUI
2700756
RxNorm name
denileukin diftitox-cxdl 0.3 MG Injection [Lymphir]
Display name
denileukin diftitox-cxdl 0.3 MG Injection [Lymphir]
Full name
denileukin diftitox-cxdl 0.3 MG Injection [Lymphir]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761312Lymphirdenileukin diftitox-cxdl351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LYMPHIRDENILEUKIN DIFTITOX-CXDLCitius Pharmaceuticals, Inc.ac3613d7-4304-40e7-a3f5-adb8a8adca5d2025-01-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2700756

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ac3613d7-4304-40e7-a3f5-adb8a8adca5ddenileukin diftitox-cxdl 0.3 MG Injection [Lymphir]SBD7These highlights do not include all the information needed to use LYMPHIR™ safely and effectively. See full prescribing information for LYMPHIR. LYMPHIR™ (denileukin diftitox-cxdl) for injection, for intravenous use Initial U.S. Approval: 202420250123
ac3613d7-4304-40e7-a3f5-adb8a8adca5dLymphir 0.3 MG InjectionSY7These highlights do not include all the information needed to use LYMPHIR™ safely and effectively. See full prescribing information for LYMPHIR. LYMPHIR™ (denileukin diftitox-cxdl) for injection, for intravenous use Initial U.S. Approval: 202420250123
ac3613d7-4304-40e7-a3f5-adb8a8adca5dLymphir 300 MCG InjectionSY7These highlights do not include all the information needed to use LYMPHIR™ safely and effectively. See full prescribing information for LYMPHIR. LYMPHIR™ (denileukin diftitox-cxdl) for injection, for intravenous use Initial U.S. Approval: 202420250123
ac3613d7-4304-40e7-a3f5-adb8a8adca5dLYMPHIR 300 MCG InjectionPSN7These highlights do not include all the information needed to use LYMPHIR™ safely and effectively. See full prescribing information for LYMPHIR. LYMPHIR™ (denileukin diftitox-cxdl) for injection, for intravenous use Initial U.S. Approval: 202420250123